The manufacturer of ciclesonide inhalers (Alvesco®) has written to healthcare professionals advising of an imminent supply interruption to this product.
Ciclesonide is available in 80 microgram and 160 microgram dose strengths. Due to a supply issue affecting one of the components of the inhaler, stock in the UK is running very low and supplies are not assured from the start of August. The 80 microgram strength is expected back in supply by mid-October with the 160 microgram strength due back from mid-September.
Pharmacies are being advised to contact prescribers for an alternative if prescriptions cannot be dispensed. Prescribers are being advised to consider appropriate alternatives where necessary. The BTS/SIGN guideline on the management of asthma is a useful resource for identifying dose equivalence.
Action: Clinicians should be aware of this supply interruption and be prepared to supply appropriate alternatives.
|« CKS Updates - August 2018||SMC Update - September 2018 »|